Overview:

**COVID-19 RELATION**Verapamil is a phenylalkylamine calcium channel blocking compound, which inhibits the transmembrane influx of calcium ions into the cells. The inhibitory potential of verapamil halting the replication of many viruses such as influenza A, MARV, Ebola virus has been well documented. Verapamil also targets the Multidrug resistance-associated protein 1 (MRP1), which studies have shown, interacts with the SARS-CoV-2 Orf9c protein. Breaking this link can prove to be a successful therapeutic intervention against the SARSCOV2 virus. **L-type calcium channel blocker (1). Clinically useful for the treatment of hypertension and coronary artery disease (2). Binds to and inhibits P-glycoprotein and reverses multidrug resistance in multidrug-resistant CHO cells (3,4). Induces autophagy (5).

References:

1. L Lacinova et al. J. Pharmacol. Exp. Ther. 1995 274:542. RN Brogdan and P Benfield Drugs 1996 51:792 3. AR Safa et al. J. Biol. Chem. 1987 262:78844. M Chatterjee et al. Cancer Res. 1990 50:28185. A Fleming Nat. Chem. Biol. 2011 7:9